DK120383A - Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning - Google Patents

Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning Download PDF

Info

Publication number
DK120383A
DK120383A DK120383A DK120383A DK120383A DK 120383 A DK120383 A DK 120383A DK 120383 A DK120383 A DK 120383A DK 120383 A DK120383 A DK 120383A DK 120383 A DK120383 A DK 120383A
Authority
DK
Denmark
Prior art keywords
muramyl
hapten
peptid
conjugates
procedure
Prior art date
Application number
DK120383A
Other languages
Danish (da)
English (en)
Other versions
DK120383D0 (da
Inventor
Francoise Audibert
Claude Carelli
Louis Chedid
Pierre Lefrancier
Michel Level
Jean Choay
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of DK120383D0 publication Critical patent/DK120383D0/da
Publication of DK120383A publication Critical patent/DK120383A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK120383A 1982-03-15 1983-03-15 Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning DK120383A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8204353A FR2522967B1 (fr) 1982-03-15 1982-03-15 Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Publications (2)

Publication Number Publication Date
DK120383D0 DK120383D0 (da) 1983-03-15
DK120383A true DK120383A (da) 1983-09-16

Family

ID=9272016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK120383A DK120383A (da) 1982-03-15 1983-03-15 Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning

Country Status (12)

Country Link
US (1) US4639512A (de)
EP (1) EP0089290B1 (de)
JP (1) JPH0720882B2 (de)
AT (1) ATE43968T1 (de)
AU (1) AU570405B2 (de)
CA (1) CA1193216A (de)
DE (1) DE3380053D1 (de)
DK (1) DK120383A (de)
ES (1) ES8608883A1 (de)
FR (1) FR2522967B1 (de)
HU (1) HU195620B (de)
SU (1) SU1331433A3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
DE4010645A1 (de) * 1990-02-10 1991-08-14 Gerhard Dr Prinzhaus Synthetisches peptid: thymosin (alpha)(pfeil abwaerts)1(pfeil abwaerts) - mdp - lys (t (alpha)(pfeil abwaerts)1(pfeil abwaerts)-nacmur-l-ala-d-isogln-l-lys)
FR2732604B1 (fr) * 1995-04-07 1997-06-06 Vacsyn Sa Derives et conjugues du mdp presentant une activite stimulatrice de la fonction hematopoietique et compositions les contenant
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
US6561915B2 (en) * 2001-10-09 2003-05-13 Mattel, Inc. Infant swing and method of using the same
AU2004209644A1 (en) * 2003-02-03 2004-08-19 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
US9403908B2 (en) * 2003-09-29 2016-08-02 The Regents Of The University Of California Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
WO2009014782A2 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
JP6709797B2 (ja) 2014-11-21 2020-06-17 ボヴィン、ニコライ ウラジミロヴィチＢＯＶＩＮ，Ｎｉｃｏｌａｉ Ｖｌａｄｉｍｉｒｏｖｉｃｈ 多価リガンド−脂質構築物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292486A1 (fr) * 1974-07-01 1976-06-25 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
IL48325A (en) * 1974-10-22 1979-05-31 Anvar Immunological-free adjuvant compositions containing n-acetyl muramyl-alanyl-d-isoglutamine or n-acetyl-muramyl-l-alanyl-d-glutamicn acid
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation

Also Published As

Publication number Publication date
HU195620B (en) 1988-06-28
JPH0720882B2 (ja) 1995-03-08
JPS58208237A (ja) 1983-12-03
FR2522967A1 (fr) 1983-09-16
EP0089290A1 (de) 1983-09-21
EP0089290B1 (de) 1989-06-14
US4639512A (en) 1987-01-27
DE3380053D1 (en) 1989-07-20
DK120383D0 (da) 1983-03-15
SU1331433A3 (ru) 1987-08-15
CA1193216A (fr) 1985-09-10
AU1248583A (en) 1983-09-22
ATE43968T1 (de) 1989-06-15
AU570405B2 (en) 1988-03-17
ES8608883A1 (es) 1986-07-16
ES520915A0 (es) 1986-07-16
FR2522967B1 (fr) 1986-03-07

Similar Documents

Publication Publication Date Title
DK120383A (da) Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning
ES2179105T3 (es) Adyuvantes proteinicos.
FI903292A0 (fi) T-cellepitop som baerarmolekyler foer konjugerade vacciner.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
DK2181715T3 (da) Kunstige T-hjælpecelle-epitoper som immunstimulatorer for syntetiske peptidimmunogener
ATE212233T1 (de) Impfstoffe gegen neisseria meningitidis gruppe c
PT98156A (pt) Um processo de preparacao de uma composicao de vacina
DK0498851T3 (da) Tumorassocieret urinantigen, anvendelse af antigene underenheder og fremgangsmåder til detektion
DK218886A (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
ATE52251T1 (de) Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
SE7910089L (sv) Vacciner
DK547279A (da) E fremgangsmaade til fremstilling af inaktiveret reovirusvaccin
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
DK1183044T3 (da) Adjuvanskombinationer til immunisering og vacciner
FR2462166B1 (fr) Compositions antigeniques, leur preparation et vaccins a base de ces compositions
HUANG et al. Characterization of antigenicity of the outer membrane protein from Edwardsiella tarda
CO5241277A1 (es) Vacuna
DK0563288T3 (da) Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner
SE8400934L (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment